Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes

Lian Engelen, Soren S. Lund, Isabel Ferreira, Lise Tarnow, Hans-Henrik Parving, Jorgen Gram, Kaj Winther, Oluf Pedersen, Tom Teerlink, Rob Barto, Coen D. A. Stehouwer, Allan A. Vaag, Casper G. Schalkwijk*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Web of Science)
Original languageEnglish
Pages (from-to)371-379
JournalEuropean Journal of Endocrinology
Issue number3
Publication statusPublished - Mar 2011

Cite this